N. David Eansor's most recent trade in Marker Therapeutics Inc was a trade of 137,330 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2025 | 137,330 | 137,330 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2025 | 84,411 | 84,411 | - | - | Stock Option (Right to Buy) | |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Marker Therapeutics Inc | N. David Eansor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 12 Nov 2021 | 27,159 | 28,477 (0%) | 0% | 125.1 | 3,396,233 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 27,159 | 799 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 503.61 per share. | 12 Nov 2021 | 9,043 | 13,243 (0%) | 0% | 503.6 | 4,554,137 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.39 per share. | 12 Nov 2021 | 8,989 | 4,254 (0%) | 0% | 504.4 | 4,533,985 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 502.77 per share. | 12 Nov 2021 | 4,054 | 22,286 (0%) | 0% | 502.8 | 2,038,221 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 505.49 per share. | 12 Nov 2021 | 2,535 | 1,719 (0%) | 0% | 505.5 | 1,281,407 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 799 | 0 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 12 Nov 2021 | 799 | 2,117 (0%) | 0% | 125.1 | 99,915 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.09 per share. | 12 Nov 2021 | 700 | 27,777 (0%) | 0% | 504.1 | 352,860 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.14 per share. | 12 Nov 2021 | 537 | 26,740 (0%) | 0% | 504.1 | 270,725 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 506.24 per share. | 12 Nov 2021 | 401 | 1,318 (0%) | 0% | 506.2 | 203,002 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 505.00 per share. | 12 Nov 2021 | 400 | 26,340 (0%) | 0% | 505.0 | 202,002 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 502.99 per share. | 12 Nov 2021 | 300 | 27,277 (0%) | 0% | 503.0 | 150,897 | Common Stock |
| Bio-Techne | N. David Eansor | President-Protein Sciences | Sale of securities on an exchange or to another person at price $ 504.78 per share. | 12 Nov 2021 | 200 | 27,577 (0%) | 0% | 504.8 | 100,956 | Common Stock |